This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-CD45 monoclonal antibody, clone B30 [PE/Cy7®]
catalog :
DCABH-4488
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
PE/Cy7
clone name :
IJ41
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-4488
Product Name :
Anti-CD45 monoclonal antibody, clone B30 [PE/Cy7®]
Brand :
Creative Diagnostics
Abbr :
Anti-PTPRC MAb, PE/Cy7®-Conjugated
Host animal :
Mouse
Clone :
IJ41
Official Symbol :
PTPRC
Clonality :
Monoclonal
Application :
FC
Target :
PTPRC
Species Reactivity :
Human
Conjugate :
PE/Cy7®
Antibody Type :
Primary Antibodies
Immunogen :
Full length version of the CD45 protein
Alternative Names :
PTPRC; protein tyrosine phosphatase, receptor type, C; CD45; receptor-type tyrosine-protein phosphatase C; GP180; LCA; T200; CD45 antigen; T200 glycoprotein; leukocyte common antigen; leukocyte-common antigen; T200 leukocyte common antigen; protein tyrosi
UniProt ID :
M9MML4
Antibody Isotype :
IgG1
Size :
50 Tests
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments